Ophiocordyceps sinensis: decoding its journey— from snowy legends to modern science

Abstract

Ophiocordyceps sinensis (Berk) Sacc. ( O. sinensis; Family: Clavicipitaceae; synonym: Cordyceps sinensis) is a fungus that is revered in ancient Tibetan folklore as a “miraculous species that becomes a worm in winter and a grass in summer” and renowned as the “elixir of life gifted” by the snow-capped region. Its evolutional awareness and utilization span both traditional Chinese medicine practices and modern biomedical research, rendering it a quintessential example of symbiotic entomo-fungal biological resource development. Extensive research on the biological characteristics, active constituents, pharmacological effects, and underlying mechanisms of O. sinensis has generated significant breakthroughs in recent years. From “heavenly elixir” to a vital tonic in imperial cuisine, and from its symbiotic life cycle to its current prominence in modern pharmacological research and clinical applications, this fungus has nurtured both the cultural legends and survival wisdom of the Plateau ancestors and reflected the long journey of contemporary scientific exploration and industrialization. This review traces the journey of O. sinensis from traditional empirical applications to scientific validation, focusing on its biological characteristics, extraction and separation techniques for key bioactive constituents, and its pharmacological effects and molecular mechanisms in antitumor activity, immunomodulation, renoprotection, antioxidant properties, and anti-aging effects, and summarizes the current status of its clinical applications. Furthermore, this review examines the challenges confronting current research on O. sinensis, including resource conservation and sustainable utilization, quality control and standardization, differences between artificially cultivated and wild-harvested specimens, further elucidating its mechanisms of action and outlining prospects for future research directions.

Keywords

Active constituents / Clinical applications / Extraction and separation techniques / Ophiocordyceps sinensis / Pharmacological effects

References

[1] Li YL, Li XZ, Yao YS, et al. Differential coexistence of multiple genotypes of Ophiocordyceps sinensis in the stromata, ascomycetes and ascospores of natural Cordyceps sinensis. PLoS One 2023; 18(3): e0270776.

[2] Khalid MZ, Zheng X, Han R, et al. Fusarium pseudonygamai promotes blastospore transformation in Ophiocordyceps sinensis: insights into microbial interaction and key mechanisms. J Fungi (Basel) 2025; 11(10): 746.

[3] Chai WM, Mao XB, Li CF, et al. Neurotransmitter acetylcholine mediates the mummification of Ophiocordyceps sinensis—infected Thitarodes xiaojinensis larvae. Appl Environ Microbiol 2024; 90(9): e0033324.

[4] Hsu CC, Tsai SJ, Huang YL, et al. Regulatory mechanism of Cordyceps sinensis mycelium on mouse Leydig cell steroidogenesis. FEBS Lett 2003; 543(1—3): 140-143.

[5] Li CP, Tang DX, Wang YB, et al. Endogenous bacteria inhabiting the Ophiocordyceps highlandensis during fruiting body development. BMC Microbiol 2021; 21(1): 178.

[6] Liu HJ, Hu HB, Chu C, et al. Morphological and microscopic identification studies of Cordyceps and its counterfeits. Acta Pharm Sin B 2011; 1: 189-195.

[7] Guo LX, Xu XM, Liang FR, et al. Morphological observations and fatty acid composition of indoor—cultivated Cordyceps sinensis at a high—altitude laboratory on Sejila Mountain, Tibet. PLoS One 2015; 10(5): e0126095.

[8] Wang T, Tang CY, Xiao MJ, et al. Characteristics of lipid accumulation induced by high—altitude environment improve the total antioxidant capacity of Ophiocordyceps sinensis. Food Chem 2025; 480: 143812.

[9] Dai YD, Chen SQ, Wang YB, et al. Molecular phylogenetics of the Ophiocordyceps sinensis—species complex lineage (Ascomycota, Hypocreales), with the discovery of new species and predictions of species distribution. IMA Fungus 2024; 15(1): 2.

[10] Kang XC, Hu LQ, Shen PY, et al. SMRT sequencing revealed mitogenome characteristics and mitogenome—wide DNA modification pattern in Ophiocordyceps sinensis. Front Microbiol 2017; 8: 1422.

[11] Zhang H, Yue P, Tong XX, et al. Comparative analysis of fatty acid metabolism based on transcriptome sequencing of wild and cultivated Ophiocordyceps sinensis. PeerJ 2021; 9: e11681.

[12] Singh M, Tulsawani R, Koganti P, et al. Cordyceps sinensis increases hypoxia tolerance by inducing heme oxygenase—1 and metallothionein via Nrf2 activation in human lung epithelial cells. Biomed Res Int 2013; 2013: 569206.

[13] Rajput R, Sharma P, Mishra J, et al. Bioactive fractions from the Chinese caterpillar mushroom, Ophiocordyceps sinensis (ascomycetes), elucidate adaptogenic role against hypoxia stress. Int J Med Mushrooms 2020; 22(11): 1121-1133.

[14] Mishra J, Rajput R, Singh K, et al. Antioxidant—rich peptide fractions derived from high—altitude Chinese caterpillar medicinal mushroom Ophiocordyceps sinensis (ascomycetes) inhibit bacterial pathogens. Int J Med Mushrooms 2019; 21(2): 155-168.

[15] Subedi A, Hamal S, Joshi A. A review on Ophiocordyceps sinensis. Sci Herit J 2023; 7: 71-75.

[16] Krishna KV, Balasubramanian B, Park S, et al. Conservation of endangered Cordyceps sinensis through artificial cultivation strategies of C. militaris, an alternate. Mol Biotechnol 2025; 67(4): 1382-1397.

[17] Zhang JS, Wang N, Chen WX, et al. Integrated metabolomics and transcriptomics reveal metabolites difference between wild and cultivated Ophiocordyceps sinensis. Food Res Int 2023; 163: 112275.

[18] Wang T, Xiao MJ, Tang CY, et al. Transcriptomics and metabolomics provide the difference of unique odor between natural and cultivated Ophiocordyceps sinensis and the biosynthetic pathway of key volatile compounds. Food Biosci 2025; 66: 106200.

[19] Gu X, Li YP, Li Y, et al. Integrating 2D NMR—based metabolomics and in vitro assays to explore the potential viability of cultivated Ophiocordyceps sinensis as an alternative to the wild counterpart. J Pharm Biomed Anal 2025; 253: 116551.

[20] Zheng J, Huo XK, Wang Y, et al. Comparative study on the immune enhancement and anti—aging activities between cultivated and wild Cordyceps sinensis . Chin Pharm J 2018; 53(20): 1742-1747.

[21] Dong ZH, Sun X. Chemical components in cultivated Cordyceps sinensis and their effects on fibrosis. Chin Herb Med 2024; 16(1): 162-167.

[22] Wang GL, Jin HY, Han XP, et al. Quality research and existing problems of Cordyceps sinensis medicinal materials. Chin Tradit Herb Drugs 2008; 01: 115-118.

[23] Lu H, Xu N, Meng FY. Content determination and health risk assessment of heavy metals in Cordyceps sinensis. Environ Chem 2017; 36(5): 1003-1008.

[24] Qiu XH, Cao L, Han RC. Determination of heavy metal content in Cordyceps sinensis, plants and soil. J Environ Entomol 2020; 42(2): 267-273. In Chinese.

[25] Yang P, Zhao XX, Zhang YW. Standard comparison and evaluation of fermented Cordyceps products. China J Chin Mater Med 2018; 43(3): 463-468.

[26] Liu J, Li YL, Zan K, et al. Comparison of the contents of five heavy metals and harmful elements in cultivated and wild Cordyceps sinensis. Chin Pharm Aff 2016; 30(9): 912-918.

[27] Sun T, Zou WQ, Luo R, et al. Compositional and functional diversities of core microbial communities in wild and artificial Ophiocordyceps sinensis. Int Microbiol 2023; 26(4): 791-806.

[28] Guo DL, Qiu L, Feng D, et al. Three new α—pyrone derivatives induced by chemical epigenetic manipulation of Penicillium herquei, an endophytic fungus isolated from Cordyceps sinensis. Nat Prod Res 2020; 34(7): 958-964.

[29] Li XH, Han XH, Qin LL, et al. Isochromanes from Aspergillus fumigatus, an endophytic fungus from Cordyceps sinensis. Nat Prod Res 2019; 33(13): 1870-1875.

[30] Zhang JM, Yang ZL, Zhao Z, et al. Structural and pharmacological insights into cordycepin for neoplasms and metabolic disorders. Front Pharmacol 2024; 15: 1367820.

[31] He R, Zhou WC. Application and research progress of cordycepin in the treatment of tumours (Review). Mol Med Rep 2024; 30(3): 161.

[32] Songprakhon P, Panya A, Choomee K, et al. Cordycepin exhibits both antiviral and anti—inflammatory effects against dengue virus infection. iScience 2024; 27(9): 110711.

[33] Tan L, Song XMT, Ren YL, et al. Anti—inflammatory effects of cordycepin: a review. Phytother Res 2020; 35: 1284-1297.

[34] Di Lorenzo R, Falanga D, Ricci L, et al. NAD—driven sirtuin activation by Cordyceps sinensis extract: exploring the adaptogenic potential to promote skin longevity. Int J Mol Sci 2024; 25(8): 4282.

[35] Yan XF, Zhang ZM, Yao HY, et al. Cardiovascular protection and antioxidant activity of the extracts from the mycelia of Cordyceps sinensis act partially via adenosine receptors. Phytother Res 2013; 27(11): 1597-1604.

[36] Khan MS, Parveen R, Mishra K, et al. Determination of nucleosides in Cordyceps sinensis and Ganoderma lucidum by high performance liquid chromatography method. J Pharm Bioallied Sci 2015; 7(4): 264-266.

[37] Zhou YJ, Wang M, Zhang H, et al. Comparative study of the composition of cultivated, naturally grown Cordyceps sinensis, and stiff worms across different sampling years. PLoS One 2019; 14(12): e0225750.

[38] Wang Y, Wang Y, Liu D, et al. Cordyceps sinensis polysaccharide inhibits PDGF—BB—induced inflammation and ROS production in human mesangial cells. Carbohydr Polym 2015; 125: 135-145.

[39] Zhang XF, Qiao YJ, Li GQ, et al. Exploratory studies of the antidepressant effect of Cordyceps sinensis polysaccharide and its potential mechanism. Int J Biol Macromol 2024; 277(Pt 2): 134281.

[40] Qi WC, Zhou XT, Wang JQ, et al. Cordyceps sinensis polysaccharide inhibits colon cancer cells growth by inducing apoptosis and autophagy flux blockage via mTOR signaling. Carbohydr Polym 2020; 237: 116113.

[41] Jayakumar T, Chiu CC, Wang SH, et al. Anti—cancer effects of CME—1, a novel polysaccharide, purified from the mycelia of Cordyceps sinensis against B16—F10 melanoma cells. J Cancer Res Ther 2014; 10(1): 43-49.

[42] Yang SL, Zhang H. Production of intracellular selenium—enriched polysaccharides from thin stillage by Cordyceps sinensis and its bioactivities. Food Nutr Res 2016; 60: 30153.

[43] Wang WE. Polysaccharides as quality marker to rapid profile for Ophiocordyceps sinensis by PXRD. Molecules 2024; 29(13): 3201.

[44] Qian ZM, Li SF, Liu XP, et al. Structure characterization and in vitro immunomodulatory effects of a novel galactoglucomannan in cultivated Chinese Cordyceps (Cordyceps sinensis). Carbohydr Polym 2026; 371: 124520.

[45] Wang WH, Zhuang SS, Chen BY, et al. Comprehensive identification and discovery of novel sterol compounds in Cordyceps sinensis and related species. Food Chem 2025; 490: 145060.

[46] Peng Y, Tao YY, Wang QL, et al. Ergosterol is the active compound of cultured mycelium Cordyceps sinensis on antiliver fibrosis. Evid Based Complement Alternat Med 2014; 2014: 537234.

[47] Sun X, Feng XL, Zheng DD, et al. Ergosterol attenuates cigarette smoke extract—induced COPD by modulating inflammation, oxidative stress and apoptosis in vitro and in vivo. Clin Sci (Lond) 2019; 133(13): 1523-1536.

[48] Matsuda H, Akaki J, Nakamura S, et al. Apoptosis—inducing effects of sterols from the dried powder of cultured mycelium of Cordyceps sinensis. Chem Pharm Bull (Tokyo) 2009; 57(4): 411-414.

[49] Rangsinth P, Sharika R, Pattarachotanant N, et al. Potential beneficial effects and pharmacological properties of ergosterol, a common bioactive compound in edible mushrooms. Foods 2023; 12(13): 2529.

[50] Paterska M, Czerny B, Cielecka—Piontek J. Macrofungal extracts as a source of bioactive compounds for cosmetical anti—aging therapy: a comprehensive review. Nutrients 2024; 16(16): 2810.

[51] Bok JW, Lermer L, Chilton J, et al. Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochem 1999; 51(7): 891-898.

[52] Bocachica—Adorno AL, Aponte—Ramos AY, Rivera—Fuentes PS, et al. Ergosterol peroxide disrupts triple—negative breast cancer mitochondrial function and inhibits tumor growth and metastasis. Int J Mol Sci 2025; 26(10): 4588.

[53] Luo R, Zhao HY, Deng SQ, et al. Discovery and optimization of ergosterol peroxide derivatives as novel glutaminase 1 inhibitors for the treatment of triple—negative breast cancer. Molecules 2024; 29(18): 4375.

[54] Ling TT, Arroyo—Cruz LV, Smither WR, et al. Early preclinical studies of ergosterol peroxide and biological evaluation of its derivatives. ACS Omega 2024; 9(35): 37117-37127.

[55] Zhu ZY, Yao Q, Liu Y, et al. Highly efficient synthesis and antitumor activity of monosaccharide saponins mimicking components of Chinese folk medicine Cordyceps sinensis. J Asian Nat Prod Res 2012; 14(5): 429-435.

[56] Liu Y, Guo ZJ, Zhou XW. Chinese Cordyceps: bioactive components, antitumor effects and underlying mechanism—a review. Molecules 2022; 27(19): 6576.

[57] Samarasinghe K, Waisundara VY. Therapeutic properties and anti—lipidemic activity of Cordyceps sinensis. In: Waisundara VY, Jovandaric MZ, editors. Apolipoproteins, Triglycerides and Cholesterol. Chapter 10. IntechOpen; 2020.

[58] Zhang JS, Yu H, Li SS, et al. Comparative metabolic profiling of Ophiocordyceps sinensis and its cultured mycelia using GC—MS. Food Res Int 2020; 134: 109241.

[59] Yao CL, Qian ZM, Tian WS, et al. Profiling and identification of aqueous extract of Cordyceps sinensis by ultra—high performance liquid chromatography tandem quadrupole—orbitrap mass spectrometry. Chin J Nat Med 2019; 17(8): 631-640.

[60] Maľučká LU, Uhrinová A, Lysinová P. Medicinal mushrooms Ophiocordyceps sinensis and Cordyceps militaris. Ceska Slov Farm 2022; 71(6): 259-265.

[61] Zhang Y, Liu J, Wang Y, et al. Nucleosides and amino acids, isolated from Cordyceps sinensis, protected against cyclophosphamide—induced myelosuppression in mice. Nat Prod Res 2022; 36(23): 6056-6059.

[62] Booi HN, Pang LY, Lee MK, et al. Evidence to support cultivated fruiting body of Ophiocordyceps sinensis (Ascomycota)’s role in relaxing airway smooth muscle. J Ethnopharmacol 2025; 336: 118727.

[63] Tang CY, Li XZ, Wang T, et al. Characterization of metabolite landscape distinguishes medicinal fungus Cordyceps sinensis and other Cordyceps by UHPLC—Q exactive HF—X untargeted metabolomics. Molecules 2023; 28(23): 7745.

[64] He M, Tang CY, Wang T, et al. Analysis of metabolic profiles and antioxidant activity of Chinese Cordyceps, Ophiocordyceps sinensis, and Paecilomyces hepiali based on untargeted metabolomics. Biology (Basel) 2024; 13(9): 683.

[65] He L, Xie F, Xia XY, et al. Uncovering gene expression profiles of three morphologic mycelium forms of the Chinese caterpillar mushroom Ophiocordyceps sinensis (Ascomycota) using high—throughput sequencing. Int J Med Mushrooms 2023; 25(4): 75-92.

[66] Wang T, Tang C, He H, et al. Evaluation of Cordyceps sinensis quality in 15 production areas using metabolomics and the membership function method. J Fungi (Basel) 2024; 10(5): 356.

[67] Xiao MJ, Wang T, Tang CY, et al. Effects of drying methods on morphological characteristics, metabolite content, and antioxidant capacity of Cordyceps sinensis. Foods 2024; 13(11): 1639.

[68] Yuan QH, Xie F, Tan J, et al. Extraction, structure and pharmacological effects of the polysaccharides from Cordyceps sinensis: a review. J Funct Foods 2022; 89: 104909.

[69] Chen SP, Wang JQ, Fang QY, et al. Polysaccharide from natural Ophiocordyceps sinensis alleviated dextran sulfate sodium—induced colitis through modulating sIgA formation and gut microbiota. J Funct Foods 2025; 131: 106921.

[70] Shashidhar MG, Manohar B. Acidified hot water extraction of Adenosine, Cordycepin, and Polysaccharides from the Chinese caterpillar mushroom, Ophiocordyceps sinensis CS1197 (Ascomycetes): application of an artificial neural network and evaluation of antioxidant and antibacterial activities. Int J Med Mushrooms 2016; 18(10): 915-926.

[71] Liu Y, Yang JY, Guo ZJ, et al. Immunomodulatory effect of Cordyceps militaris polysaccharide on RAW 264.7 macrophages by regulating MAPK signaling pathways. Molecules 2024; 29(14): 3408.

[72] Krishna KV, Ulhas RS, Malaviya A. Bioactive compounds from Cordyceps and their therapeutic potential. Crit Rev Biotechnol 2024; 44(5): 753-773.

[73] Wang YW, Zhang B, Guo MJ, et al. Rapid detection of cordycepin in food by surface—enhanced Raman technique. J Future Foods 2023; 3(1): 24-28.

[74] Zhang HY, Li YH, Mi JN, et al. GC—MS profiling of volatile components in different fermentation products of Cordyceps sinensis mycelia. Molecules 2017; 22(10): 1800.

[75] He BL, Guo LQ, Zheng QW, et al. A simple and effective method using macroporous resins for the simultaneous decoloration and deproteinisation of Cordyceps militaris polysaccharides. Int J Food Sci Technol 2019; 54(5): 1741-1751.

[76] Yan JK, Wang WQ, Wu JY. Recent advances in Cordyceps sinensis polysaccharides: Mycelial fermentation, isolation, structure, and bioactivities: a review. J Funct Foods 2014; 6: 33-47.

[77] Li ZG, Chen AL, Li ZC, et al. A novel and environmentally friendly bioprocess for separation and partial purification of polysaccharides from Cordyceps sinensis mycelia by an aqueous two—phase system. RSC Adv 2017; 7: 37659-37665.

[78] Zhang JL, Yu YC, Zhang ZF, et al. Effect of polysaccharide from cultured Cordyceps sinensis on immune function and anti—oxidation activity of mice exposed to 60Co. Int Immunopharmacol 2011; 11(12): 2251-2257.

[79] Wu YL, Sun CR, Pan YJ. Structural analysis of a neutral (1→3),(1→4)—β—d—glucan from the mycelia of Cordyceps sinensis. J Nat Prod 2005; 68(5): 812-814.

[80] Gao ZY, Zhou YP, Zhang YH, et al. Ultrasonic—assisted deep eutectic solvent extraction: process optimization of Cordycepin from Cordyceps sinensis and antioxidant activity evaluation. Microchem J 2025; 218: 115681.

[81] Wang HJ, Pan MC, Chang CK, et al. Optimization of ultrasonic—assisted extraction of cordycepin from Cordyceps militaris using orthogonal experimental design. Molecules 2014; 19(12): 20808-20820.

[82] Wang XY, Zhang JY, Zhang K, et al. Ultrasound—assisted enzyme extraction, physicochemical properties and antioxidant activity of polysaccharides from Cordyceps militaris solid medium. Molecules 2024; 29(19): 4560.

[83] Guan J, Yang FQ, Li SP. Evaluation of carbohydrates in natural and cultured Cordyceps by pressurized liquid extraction and gas chromatography coupled with mass spectrometry. Molecules 2010; 15(6): 4227-4241.

[84] Katiyar D, Ghosh D, Singh R, et al. Medicinal mushrooms: bioactive components, pharmacological, immunological and toxicological insights. ChemistrySelect 2025; 10: e01956.

[85] Zhu ZY, Dong FY, Liu XC, et al. Effects of extraction methods on the yield, chemical structure and anti—tumor activity of polysaccharides from Cordyceps gunnii mycelia. Carbohydr Polym 2016; 140: 461-471.

[86] Liu QB, Lu JG, Jiang ZH, et al. In situ chemical profiling and imaging of cultured and natural Cordyceps sinensis by TOF—SIMS. Front Chem 2022; 10: 862007.

[87] Shao LW, Huang LH, Yan S, et al. Cordycepin induces apoptosis in human liver cancer HepG2 cells through extrinsic and intrinsic signaling pathways. Oncol Lett 2016; 12(2): 995-1000.

[88] Wu SZ, Lan YY, Chen CY, et al. Cordycepin activates autophagy to suppress FGF9—induced TM3 mouse Leydig progenitor cell proliferation. Cancer Genomics Proteomics 2024; 21(6): 630-644.

[89] Lu TM, Zhou LR, Chu Z, et al. Cordyceps sinensis relieves non—small cell lung cancer by inhibiting the MAPK pathway. Chin Med 2024; 19(1): 54.

[90] Su NW, Wu SH, Chi CW, et al. Cordycepin, isolated from medicinal fungus Cordyceps sinensis, enhances radiosensitivity of oral cancer associated with modulation of DNA damage repair. Food Chem Toxicol 2019; 124: 400-410.

[91] Cai HW, Li J, Gu BH, et al. Extracts of Cordyceps sinensis inhibit breast cancer cell metastasis via down—regulation of metastasis—related cytokines expression. J Ethnopharmacol 2018; 214: 106-112.

[92] Chen LP, Liu X, Zheng KY, et al. Cordyceps polysaccharides: a review of their immunomodulatory effects. Molecules 2024; 29(21): 5107.

[93] Li S, Pang W, Wang YZ, et al. Cordyceps sinensis extract protects against acute kidney injury by inhibiting perforin expression in NK cells via the STING/IRF3 pathway. Aging (Albany, NY) 2024; 16(7): 5887-5904.

[94] Li DG, Ren ZX. Cordyceps sinensis promotes immune regulation and enhances bacteriostatic activity of PA—824 via IL—10 in Mycobacterium tuberculosis disease. Braz J Med Biol Res 2017; 50(9): e6188.

[95] Nie HY, Ge J, Liu KG, et al. Moxifloxacin plus Cordyceps polysaccharide ameliorate intestinal barrier damage due to abdominal infection via anti—inflammation and immune regulation under simulated microgravity. Life Sci Space Res (Amst) 2025; 44: 23-37.

[96] Li J, Cai HW, Sun HH, et al. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF—κB pathway activation. J Ethnopharmacol 2020; 260: 112969.

[97] Liu Y, Li QZ, Li LD, et al. Immunostimulatory effects of the intracellular polysaccharides isolated from liquid culture of Ophiocordyceps sinensis (Ascomycetes) on RAW264.7 cells via the MAPK and PI3K/Akt signaling pathways. J Ethnopharmacol 2021; 275: 114130.

[98] Ying MX, Yu Q, Zheng B, et al. Cultured Cordyceps sinensis polysaccharides modulate intestinal mucosal immunity and gut microbiota in cyclophosphamide—treated mice. Carbohydr Polym 2020; 235: 115957.

[99] Yang J, Zhou YW, Shi JS. Cordycepin protects against acute pancreatitis by modulating NF—κB and NLRP3 inflammasome activation via AMPK. Life Sci 2020; 251: 117645.

[100] Gao MY, Zhang WQ, Ma Y, et al. Bioactive polysaccharides prevent lipopolysaccharide—induced intestinal inflammation via immunomodulation, antioxidant activity, and microbiota regulation. Foods 2025; 14(15): 2575.

[101] Chen L, Yang T, Wu JP, et al. Multi—omics strategy reveals that Cordyceps sinensis ameliorates sepsis—associated acute kidney injury via reprogramming of mitochondrial energy metabolism and macrophage polarization. Acta Materia Medica 2024; 3(3): 269-288.

[102] Huang TT, Lai HC, Ko YF, et al. Hirsutella sinensis mycelium attenuates bleomycin—induced pulmonary inflammation and fibrosis in vivo. Sci Rep 2015; 5: 15282.

[103] Tao YL, Luo RX, Xiang YB, et al. Use of bailing capsules (cordyceps sinensis) in the treatment of chronic kidney disease: a meta—analysis and network pharmacology. Front Pharmacol 2024; 15: 1342831.

[104] Zhang Y, Zhou LR, Cheng GQ, et al. Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion—mediated oxidative stress. MedComm—Future Med 2024; 3(3): e91.

[105] Wu R, Gao JP, Wang HL, et al. Effects of fermented Cordyceps sinensis on oxidative stress in doxorubicin treated rats. Pharmacogn Mag 2015; 11(44): 724-731.

[106] Xiao YD, Zhang X, Huang QL. Protective effects of Cordyceps sinensis exopolysaccharide—selenium nanoparticles on H(2)O(2)—induced oxidative stress in HepG2 cells. Int J Biol Macromol 2022; 213: 339-351.

[107] Wu XQ, Li X, Chai Y, et al. Cordyceps sinensis reduces inflammation and protects BEAS—2B cells from LPS—induced THP—1 cell injury. J Inflamm Res 2025; 18: 4143-4156.

[108] Liu YY, Dou GJ, Xiao YC, et al. Therapeutic potential of Cordyceps sinensis targeting oxidative stress and inflammatory response in the treatment of COPD rats: insights from metabolomics analysis. J Asian Nat Prod Res 2025; 27(3): 460-477.

[109] Zou YX, Liu YX, Ruan MH, et al. Cordyceps sinensis oral liquid prolongs the lifespan of the fruit fly, Drosophila melanogaster, by inhibiting oxidative stress. Int J Mol Med 2015; 36(4): 939-946.

[110] Kong R, Zhang Y, Zhang SF, et al. Protective effect of ethanol extracts of the Chinese caterpillar mushroom, Ophiocordyceps sinensis (Ascomycetes), on the experimental middle cerebral artery occlusion/reperfusion (MCAO/R) model. Int J Med Mushrooms 2015; 17(10): 997-1003.

[111] Chen Y, Fu LF, Han M, et al. The prophylactic and therapeutic effects of fermented cordyceps sinensis powder, Cs—C—Q80, on subcortical ischemic vascular dementia in mice. Evid Based Complement Alternat Med 2018; 2018: 4362715.

[112] Bai X, Tan TY, Li YX, et al. The protective effect of Cordyceps sinensis extract on cerebral ischemic injury via modulating the mitochondrial respiratory chain and inhibiting the mitochondrial apoptotic pathway. Biomed Pharmacother 2020; 124: 109834.

[113] Tung CW, Chan SC, Cheng PH, et al. Exploring Cordycepin as a neuroprotective agent in Huntington’s disease: in vitro and in vivo insights. Pharmacol Res Perspect 2025; 13(2): e70091.

[114] Cheng CY, Zhu XY. Cordycepin mitigates MPTP—induced Parkinson’s disease through inhibiting TLR/NF—κB signaling pathway. Life Sci 2019; 223: 120-127.

[115] Yang L, Jiao XG, Wu JX, et al. Cordyceps sinensis inhibits airway remodeling in rats with chronic obstructive pulmonary disease. Exp Ther Med 2018; 15(3): 2731-2738.

[116] Zhou WB, Liu YY, Gao YQ, et al. Integrating proteomics, metabolomics, and network pharmacology to investigate the mechanism of Cordyceps sinensis in the treatment of COPD rats. J Pharm Biomed Anal 2025; 266: 117076.

[117] Chen M, Cheung FW, Chan MH, et al. Protective roles of Cordyceps on lung fibrosis in cellular and rat models. J Ethnopharmacol 2012; 143(2): 448-454.

[118] Shu XY, Xu DF, Qu YM, et al. Efficacy and safety of Cordyceps sinensis (Hirsutella sinensis, Cs—C—Q80) in chronic bronchitis. Front Pharmacol 2024; 15: 1428216.

[119] Wu GD, Pan A, Zhang X, et al. Cordyceps improves obesity and its related inflammation via modulation of enterococcus cecorum abundance and bile acid metabolism. Am J Chin Med 2022; 50(3): 817-838.

[120] Li F, Wu ZX, Sui X. Biotransformation of ginsenoside Rb1 with wild Cordyceps sinensis and Ascomycota sp. and its antihyperlipidemic effects on the diet—induced cholesterol of zebrafish. J Food Biochem 2020; 44(6): e13192.

[121] Yao LM, Zhu LL, Chen CL, et al. A systematic review on polysaccharides from fermented Cordyceps sinensis: advances in the preparation, structural characterization, bioactivities, structure—activity relationships. Int J Biol Macromol 2024; 282(Pt5): 137275.

[122] Zhang Q, Xiao XH, Li M, et al. Bailing capsule (Cordyceps sinensis) ameliorates renal triglyceride accumulation through the PPARα pathway in diabetic rats. Front Pharmacol 2022; 13: 915592.

[123] Dewi L, Liao YC, Jean WH, et al. Cordyceps sinensis accelerates stem cell recruitment to human skeletal muscle after exercise. Food Funct 2024; 15(8): 4010-4020.

[124] Chu CM, Chi CW, Huang CH, et al. Enhancement of swimming endurance by herbal supplement M3P. Chin J Integr Med 2022; 28(8): 725-729.

[125] Liu X, Zhong F, Tang XL, et al. Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis. Acta Pharmacol Sin 2014; 35(5): 697-706.

[126] Chen Q, Guo J, Han ST, et al. Cordycepin alleviates renal ischemia—reperfusion injury by suppressing the p38/JNK signaling pathway. Int Immunopharmacol 2025; 150: 114264.

[127] Li Y, Xue WJ, Tian PX, et al. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation. Transplant Proc 2009; 41(5): 1565-1569.

[128] Peng JH, Li XM, Feng Q, et al. Anti—fibrotic effect of Cordyceps sinensis polysaccharide: inhibiting HSC activation, TGF—β1/Smad signalling, MMPs and TIMPs. Exp Biol Med (Maywood) 2013; 238(6): 668-677.

[129] Ji Y, Tao TY, Zhang JM, et al. Comparison of effects on colitis—associated tumorigenesis and gut microbiota in mice between Ophiocordyceps sinensis and Cordyceps militaris. Phytomedicine 2021; 90: 153653.

[130] Wu TR, Lin CS, Chang CJ, et al. Gut commensal parabacteroides goldsteinii plays a predominant role in the anti—obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut 2019; 68(2): 248-262.

[131] Fan ST, Nie SP, Huang XJ, et al. Protective properties of combined fungal polysaccharides from Cordyceps sinensis and Ganoderma atrum on colon immune dysfunction. Int J Biol Macromol 2018; 114: 1049-1055.

[132] Li ZH, Zhu CS, Yin C, et al. Multi—omics reveals the testosterone promotion effect mechanism of Cordyceps Sobolifera on Leydig cells. J Ethnopharmacol 2024; 325: 117817.

[133] Zhao LN, Zhang YP, Liu M, et al. Substitution of Cordyceps cephalosporium mycelia for Cordyceps sinensis in the prescription of Shengjing capsules: enhanced effect on spermatogenesis impairment. Zhonghua Nan Ke Xue 2018; 24(7): 627-634.

[134] Liu CY, Chen CC, Chiang LH, et al. Hirsutella sinensis intensifies testicular function and spermatogenesis in male mice with high—fat diet—induced obesity. J Chin Med Assoc 2024; 87(8): 765-773.

[135] Ma GZ, Yan J. Therapeutic efficacy and pharmacological mechanism of Bailing capsule on chronic obstructive pulmonary disease: a meta—analysis and network pharmacology. Pharm Biol 2024; 62(1): 803-817.

[136] Wu D, Liu W, Wang JX, et al. Clinical application guideline of combination with traditional Chinese medicine and western medicine in the prevention and treatment of chronic obstructive pulmonary disease (2024). J Evid Based Med 2025; 18(2): e70024.

[137] Yu XH, Mao YQ, Shergis JL, et al. Effectiveness and safety of oral Cordyceps sinensis on stable COPD of GOLD stages 2—3: systematic review and meta—analysis. Evid Based Complement Alternat Med 2019; 2019: 4903671.

[138] Liu AL, Wu JX, Li AJ, et al. The inhibitory mechanism of Cordyceps sinensis on cigarette smoke extract—induced senescence in human bronchial epithelial cells. Int J Chron Obstruct Pulmon Dis 2016; 11: 1721-1731.

[139] Zang ZR, Kong YH, Kong Q. Cordyceps sinensis (CS) alleviates chronic obstructive pulmonary disease symptoms (COPD) by targeting inflammation, apoptosis, and oxidative stress through ingredient—gene—disease interaction. Immun Inflamm Dis 2025; 13(12): e70306.

[140] Zhang HW, Lin ZX, Tung YS, et al. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev 2014; 2014(12): CD008353.

[141] Hu XH, Wang J, Yang HJ, et al. Bailing Capsule combined with α—ketoacid tablets for stage 3 chronic kidney disease: protocol of a double—blinded, randomized, controlled trial. Medicine (Baltimore) 2021; 100(20): e25759.

[142] Liu W, Gao YW, Zhou Y, et al. Mechanism of Cordyceps sinensis and its extracts in the treatment of diabetic kidney disease: a review. Front Pharmacol 2022; 13: 881835.

[143] Luo Y, Yang SK, Zhou X, et al. Use of Ophiocordyceps sinensis (syn. Cordyceps sinensis) combined with angiotensin—converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) versus ACEI/ARB alone in the treatment of diabetic kidney disease: a meta—analysis. Ren Fail 2015; 37(4): 614-634.

[144] Yan GC, Chang TY, Zhao YY, et al. The effects of Ophiocordyceps sinensis combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta—analysis. Phytomedicine 2023; 108: 154531.

[145] Zhang YH, Xu LS, Lu YR, et al. Protective effect of Cordyceps sinensis against diabetic kidney disease through promoting proliferation and inhibiting apoptosis of renal proximal tubular cells. BMC Complement Med Ther 2023; 23(1): 109.

[146] Dong ZH, Sun YY, Wei GW, et al. A nucleoside/nucleobase—rich extract from Cordyceps sinensis inhibits the epithelial—mesenchymal transition and protects against renal fibrosis in diabetic nephropathy. Molecules (Basel, Switzerland) 2019; 24(22): 4119.

[147] Yuan MX, Tang R, Zhou QL, et al. Effect of Cordyceps sinensis on expressions of HIF—1α and VEGF in the kidney of rats with diabetic nephropathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2013; 38(5): 448-457.

[148] Hong T, Zhang MH, Fan JM. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Cochrane Database Syst Rev 2015; 2015(10): CD009698.

[149] Wang W, Zhang XN, Yin H, et al. Effects of Bailing capsules for renal transplant recipients: a retrospective clinical study. Chin Med J (Engl) 2013; 126(10): 1895-1899.

[150] Zhang ZH, Wang XW, Zhang YN, et al. Effect of Cordyceps sinensis on renal function of patients with chronic allograft nephropathy. Urol Int 2011; 86(3): 298-301.

[151] Ren HJ, Sun YL, Yuan B. Chinese patent medicine Bailing capsule for treating lupus nephritis: a protocol for systematic review and meta—analysis. Medicine (Baltimore) 2019; 98(37): e17041.

[152] Li Y, Xu TH, Qiu XB, et al. Effectiveness of Bailing capsules in the treatment of lupus nephritis: a meta—analysis. Mol Med Rep 2020; 22(3): 2132-2140.

[153] Su BY, Wu T, Huo LS, et al. Effects of Bailing capsules combined with levothyroxine sodium on autoimmune thyroiditis. Medicine (Baltimore) 2024; 103(48): e40713.

[154] Niwa Y, Matsuura H, Murakami M, et al. Evidence that naturopathic therapy including Cordyceps sinensis prolongs survival of patients with hepatocellular carcinoma. Integr Cancer Ther 2013; 12(1): 50-68.

[155] Wang CR, Wang JW, Qi YF. Adjuvant treatment with Cordyceps sinensis for lung cancer: a systematic review and meta—analysis of randomized controlled trials. J Ethnopharmacol 2024; 327: 118044.

[156] Marslin G, Khandelwal V, Franklin G. Cordycepin nanoencapsulated in poly(lactic—co—glycolic acid) exhibits better cytotoxicity and lower hemotoxicity than free drug. Nanotechnol Sci Appl 2020; 13: 37-45.

[157] Shen SH, Yao HY, Zhu Y, et al. Effect of a new skin—lightening cosmetic containing Cordyceps extract in the treatment of melasma: a clinical trial. J Cosmet Dermatol 2025; 24(7): e70329.

[158] Chen YY, Chen G, Zhang C, et al. Randomized, waitlist—controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong. Acta Materia Medica 2025; 4(2): 250-261.

[159] Zhao ST, Wang ZQ, Fan XX, et al. Effectiveness of fermentation broth of Cordyceps sinensis for primary insomnia: a randomized clinical trial with digital health tool. Front Neurol 2025; 16: 1555010.

[160] Wei MY, Ma WX, Zhang WH, et al. Efficacy and safety of Ophiocordyceps sinensis in the treatment of Hashimoto’s thyroiditis: a systematic review and meta—analysis. Front Pharmacol 2023; 14: 1272124.

[161] Welch J, Kole R, Daniels S. The effectiveness and efficacy of Ophiocordyceps sinensis supplementation: a systematic review of randomized clinical trials on healthy humans. Int J Herb Med 2023; 11(3): 15-22.

[162] Wei YQ, Zhang L, Wang JN, et al. Chinese caterpillar fungus (Ophiocordyceps sinensis) in China: current distribution, trading, and futures under climate change and overexploitation. Sci Total Environ 2021; 755(Pt1): 142548.

[163] Dong CH, Guo SP, Wang WF, et al. Cordyceps industry in China. Mycology 2015; 6(2): 121-129.

[164] Zhang M, Sun X, Miao YJ, et al. Cordyceps cicadae and Cordyceps gunnii have closer species correlation with Cordyceps sinensis: from the perspective of metabonomic and MaxEnt models. Sci Rep 2022; 12(1): 20469.

[165] Li Y, Wang L, Xu BJ, et al. Based on network pharmacology tools to investigate the molecular mechanism of Cordyceps sinensis on the treatment of diabetic nephropathy. J Diabetes Res 2021; 2021: 8891093.

[166] Liu M, Cui CJ, Chang TY, et al. Effects and safety of Ophiocordyceps sinensis preparation in the adjuvant treatment for dialysis patients: a systematic review and meta—analysis. Front Pharmacol 2024; 15: 1360997.

[167] Li X, Liu Q, Li WJ, et al. A breakthrough in the artificial cultivation of Chinese Cordyceps on a large—scale and its impact on science, the economy, and industry. Crit Rev Biotechnol 2019; 39(2): 181-191.

[168] Wang WZ, Bi YF, Ye JX, et al. Origin traceability of Cordyceps sinensis based on trace elements and stable isotope fingerprints. Sci Total Environ 2024; 912: 169591.

[169] Zhou L, Wang S, Hao QX, et al. Bioaccessibility and risk assessment of heavy metals, and analysis of arsenic speciation in Cordyceps sinensis. Chin Med 2018; 13: 40.

[170] Qiao J, Shuai YY, Zeng X, et al. Comparison of chemical compositions, bioactive ingredients, and in vitro antitumor activity of four products of Cordyceps (ascomycetes) strains from China. Int J Med Mushrooms 2019; 21(4): 331-342.

[171] Liu QH, Tang JW, Ma ZW, et al. Rapid discrimination between wild and cultivated Ophiocordyceps sinensis through comparative analysis of label—free SERS technique and mass spectrometry. Curr Res Food Sci 2024; 9: 100820.

[172] Arora P, Bahuguna N, Anand J, et al. Ethnopharmacology and current conservational status of Cordyceps sinensis. Z Naturforsch C J Biosci 2025; 80(7—8): 297-315.

[173] Wang ZY, Da W, Negi CS, et al. Profiling, monitoring and conserving caterpillar fungus in the Himalayan region using anchored hybrid enrichment markers. Proc Biol Sci 2022; 289(1973): 20212650.

[174] Ding B, Li HX, Huang HB, et al. Development of a mass spectrometry—based metabolomics workflow for traceability of wild and cultivated Cordyceps sinensis. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2022; 39(11): 1773-1784.

[175] Wei X, Hu HK, Zheng BG, et al. Profiling metals in Cordyceps sinensis by using inductively coupled plasma mass spectrometry. Anal Methods 2017; 9(4): 724-728.

[176] Xiao YC, Li C, Xu W, et al. Arsenic content, speciation, and distribution in wild Cordyceps sinensis. Evid Based Complement Alternat Med 2021; 2021: 6651498.

[177] Wang JB, Leger RJ S, Wang C. Advances in genomics of entomopathogenic fungi. Adv Genet 2016; 94: 67-105.

[178] Łysakowska P, Sobota A, Zarzycki P. Evaluation of the physicochemical, antioxidant and sensory properties of wheat bread with partial substitution of wheat flour with Cordyceps sinensis powder. Pol J Food Nutr Sci 2025; 75: 170-183.